Sponsored By
Oxford Biomedica (OXB) RNS Announcements
Add to Alert list| Date | Time | Source | Announcement |
|---|---|---|---|
| 01 Jul 2008 | 09:10 AM | RESPONSE TO BAVARIAN NORDIC'S | |
| 01 Jul 2008 | 07:00 AM | Board Changes | |
| 24 Jun 2008 | 07:00 AM | JEFFERIES HEALTHCARE CONFEREN | |
| 02 Jun 2008 | 07:00 AM | Trovax Phase II Trial Results | |
| 30 May 2008 | 03:28 PM | Blocklisting Return | |
| 30 May 2008 | 03:25 PM | Total Voting Rights Update | |
| 27 May 2008 | 10:25 AM | FBR Capital Markets Spring In | |
| 19 May 2008 | 07:00 AM | Rodman & Renshaw Healthcare C | |
| 16 May 2008 | 07:00 AM | Phase II Trial Results | |
| 09 May 2008 | 01:48 PM | Annual General Meeting | |
| 09 May 2008 | 07:00 AM | Interim Management Statement | |
| 30 Apr 2008 | 11:42 AM | Total Voting Rights | |
| 15 Apr 2008 | 07:00 AM | Board changes | |
| 03 Apr 2008 | 08:35 AM | Annual Information Update | |
| 01 Apr 2008 | 04:18 PM | Major Interest in Shares | |
| 31 Mar 2008 | 10:48 AM | Total Voting Rights Update | |
| 25 Mar 2008 | 10:06 AM | New Trovax Clinical Data | |
| 18 Mar 2008 | 09:09 AM | Major Interest in Shares | |
| 17 Mar 2008 | 12:32 PM | Presentation at Conference | |
| 13 Mar 2008 | 12:26 PM | Directors' Interest in Shares | |
| 10 Mar 2008 | 08:52 AM | Board Appointment | |
| 10 Mar 2008 | 07:02 AM | Phase III Trist Study | |
| 10 Mar 2008 | 07:01 AM | Preliminary Results | |
| 29 Feb 2008 | 11:43 AM | Total Voting Rights Update | |
| 20 Feb 2008 | 07:00 AM | Phase III Trist Study | |
| 19 Feb 2008 | 04:22 PM | Holding(s) in Company | |
| 15 Feb 2008 | 09:05 AM | Major Interest In Shares | |
| 13 Feb 2008 | 12:15 PM | Major Interest in Shares | |
| 07 Feb 2008 | 07:00 AM | Notification of Results | |
| 01 Feb 2008 | 10:40 AM | Notification of Shares | |
| 31 Jan 2008 | 08:57 AM | Total Voting Rights | |
| 30 Jan 2008 | 08:00 AM | Notifcation of Shares | |
| 23 Jan 2008 | 09:16 AM | Major Interest in Shares | |
| 22 Jan 2008 | 07:00 AM | Development Milestone | |
| 18 Jan 2008 | 12:53 PM | Notification of Shares | |
| 07 Jan 2008 | 07:00 AM | Exclusive License Agreement | |
| 18 Dec 2007 | 01:35 PM | Interest In Shares | |
| 13 Dec 2007 | 07:00 AM | Phase I/II Trial | |
| 10 Dec 2007 | 12:28 PM | Major Interest in Shares | |
| 10 Dec 2007 | 07:00 AM | Trovax Phase III Trial | |
| 05 Dec 2007 | 01:33 PM | Scrip's Deal of the year | |
| 29 Nov 2007 | 10:51 AM | techMARK Award | |
| 16 Nov 2007 | 11:18 AM | Block Listing | |
| 09 Nov 2007 | 07:00 AM | Broker Announcement | |
| 26 Oct 2007 | 07:01 AM | Patent Infringement Dispute | |
| 25 Oct 2007 | 11:27 AM | Director/PDMR Shareholding | |
| 25 Oct 2007 | 07:01 AM | Business Update | |
| 22 Oct 2007 | 02:57 PM | Director Shareholdings | |
| 28 Sep 2007 | 03:25 PM | Holding(s) in Company | |
| 11 Sep 2007 | 07:00 AM | Milestone in Trovax |
Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.
Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.
Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.
